Renaissance Technologies
DARE icon

Renaissance Technologies’s Dare Bioscience DARE Stock Holding History

Renaissance Technologies’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.6K Sell
10,195
-9,100
-47% -$15.6K ﹤0.01% 3176
2025
Q4 		$37.2K Sell
19,295
-39,600
-67% -$79K ﹤0.01% 3104
2025
Q3 		$124K Sell
58,895
-12,900
-18% -$29.1K ﹤0.01% 3229
2025
Q2 		$172K Buy
71,795
+1,200
+2% +$3.5K ﹤0.01% 3198
2025
Q1 		$204K Buy
70,595
+1,900
+3% +$5.9K ﹤0.01% 3071
2024
Q4 		$214K Buy
68,695
+4,300
+7% +$14.9K ﹤0.01% 3149
2024
Q3 		$209K Sell
64,395
-497
-0.8% -$1.7K ﹤0.01% 3113
2024
Q2 		$262K Buy
64,892
+1,317
+2% +$6.38K ﹤0.01% 2962
2024
Q1 		$374K Buy
63,575
+3,625
+6% +$17.8K ﹤0.01% 2990
2023
Q4 		$222K Buy
59,950
+4,050
+7% +$18.5K ﹤0.01% 3100
2023
Q3 		$310K Sell
55,900
-4,002
-7% -$32.9K ﹤0.01% 2917
2023
Q2 		$654K Buy
59,902
+12,480
+26% +$148K ﹤0.01% 2728
2023
Q1 		$592K Buy
47,422
+5,698
+14% +$75.6K ﹤0.01% 2792
2022
Q4 		$416K Sell
41,724
-12,443
-23% -$139K ﹤0.01% 3053
2022
Q3 		$650K Buy
54,167
+23,617
+77% +$324K ﹤0.01% 2757
2022
Q2 		$451K Buy
30,550
+22,188
+265% +$334K ﹤0.01% 3214
2022
Q1 		$150K Buy
+8,362
New +$158K ﹤0.01% 3718
2021
Q4 		– Sell
-27,003
Closed -$541K – 3955
2021
Q3 		$541K Buy
27,003
+20,954
+346% +$413K ﹤0.01% 2858
2021
Q2 		$137K Sell
6,049
-66,652
-92% -$1.14M ﹤0.01% 3319
2021
Q1 		$1.47M Buy
72,701
+13,726
+23% +$335K ﹤0.01% 2413
2020
Q4 		$948K Buy
58,975
+342
+0.6% +$4.79K ﹤0.01% 2523
2020
Q3 		$703K Buy
58,633
+4,293
+8% +$57.2K ﹤0.01% 2689
2020
Q2 		$645K Buy
54,340
+37,589
+224% +$461K ﹤0.01% 2773
2020
Q1 		$171K Sell
16,751
-1,404
-8% -$18.9K ﹤0.01% 3129
2019
Q4 		$179K Buy
18,155
+438
+2% +$4.26K ﹤0.01% 3218
2019
Q3 		$166K Sell
17,717
-570
-3% -$5.45K ﹤0.01% 3188
2019
Q2 		$187K Buy
18,287
+3,425
+23% +$40.7K ﹤0.01% 3312
2019
Q1 		$250K Buy
14,862
+3,733
+34% +$43.4K ﹤0.01% 3148
2018
Q4 		$95K Buy
11,129
+1,617
+17% +$17K ﹤0.01% 3239
2018
Q3 		$111K Buy
9,512
+4,175
+78% +$56.2K ﹤0.01% 3233
2018
Q2 		$75K Buy
5,337
+4,008
+302% +$53.5K ﹤0.01% 3169
2018
Q1 		$13K Buy
+1,329
New +$26.9K ﹤0.01% 3334
2017
Q1 		– Sell
-443
Closed -$38K – 3254
2016
Q4 		$38K Sell
443
-29
-6% -$2.76K ﹤0.01% 3180
2016
Q3 		$59K Sell
472
-67
-12% -$15K ﹤0.01% 3241
2016
Q2 		$137K Buy
539
+400
+288% +$128K ﹤0.01% 3117
2016
Q1 		$45K Buy
+139
New +$39.2K ﹤0.01% 3288

Other funds holding DARE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies's DARE Position: Q1 2026 in Review

Renaissance Technologies reduced its Dare Bioscience (DARE) stake by 47% in Q1 2026, selling an estimated $15.6K and leaving 10,195 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3176.

Renaissance Technologies first reported a position in DARE in Q1 2016 and has held it in 36 quarters since. The position peaked at $1.47M in Q1 2021. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • Renaissance Technologies held 10,195 shares of Dare Bioscience worth $18.6K as of Q1 2026.
  • Renaissance Technologies sold 9,100 Dare Bioscience shares in Q1 2026, an estimated $15.6K.
  • Dare Bioscience made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #3176 holding.
  • Renaissance Technologies first reported a position in Dare Bioscience in Q1 2016 and has held it in 36 quarters since.
  • Renaissance Technologies's Dare Bioscience position peaked at $1.47M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.